Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3775108
Max Phase: Preclinical
Molecular Formula: C35H56N8O10
Molecular Weight: 748.88
Molecule Type: Small molecule
Associated Items:
ID: ALA3775108
Max Phase: Preclinical
Molecular Formula: C35H56N8O10
Molecular Weight: 748.88
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCC(NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(N)=O
Standard InChI: InChI=1S/C35H56N8O10/c1-6-7-13-23(30(37)48)40-32(50)24(14-19(2)3)39-27(45)17-38-35(53)29(20(4)5)43-33(51)25(15-21-11-9-8-10-12-21)41-34(52)26(18-44)42-31(49)22(36)16-28(46)47/h8-12,19-20,22-26,29,44H,6-7,13-18,36H2,1-5H3,(H2,37,48)(H,38,53)(H,39,45)(H,40,50)(H,41,52)(H,42,49)(H,43,51)(H,46,47)/t22-,23?,24-,25-,26-,29-/m0/s1
Standard InChI Key: UYMRFLAHRMRHGI-RKVOSHEXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 748.88 | Molecular Weight (Monoisotopic): 748.4119 | AlogP: -2.06 | #Rotatable Bonds: 24 |
Polar Surface Area: 301.24 | Molecular Species: ACID | HBA: 10 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.67 | CX Basic pKa: 8.23 | CX LogP: -3.92 | CX LogD: -3.97 |
Aromatic Rings: 1 | Heavy Atoms: 53 | QED Weighted: 0.05 | Np Likeness Score: 0.05 |
1. Waszkielewicz AM, Gunia-Krzyżak A, Powroźnik B, Słoczyńska K, Pękala E, Walczak M, Bednarski M, Żesławska E, Nitek W, Marona H.. (2016) Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents., 24 (8): [PMID:26988801] [10.1016/j.bmc.2016.03.006] |
Source(1):